Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; Percepta Nasal Swab Test for lung cancer diagnosis; and Envisia Genomic Classifier for diagnosing interstitial lung disease, including idiopathic pulmonary fibrosis. It is also developing Envisia Classifier, the nCounter analysis system; and LymphMark for lymphoma subtyping test. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California. more
Time Frame | VCYT | Sector | S&P500 |
---|---|---|---|
1-Week Return | -5.4% | -0.94% | -2.6% |
1-Month Return | -0.27% | -5.08% | -1.08% |
3-Month Return | 19.64% | -10.62% | 3.45% |
6-Month Return | 78.68% | -6.18% | 8.57% |
1-Year Return | 43.62% | 1.98% | 24.3% |
3-Year Return | 1.23% | -0.93% | 25.58% |
5-Year Return | 38.43% | 33.84% | 84.07% |
10-Year Return | 401.71% | 102.52% | 185.12% |
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | 120.37M | 117.48M | 219.51M | 296.54M | 361.05M | [{"date":"2019-12-31","value":33.34,"profit":true},{"date":"2020-12-31","value":32.54,"profit":true},{"date":"2021-12-31","value":60.8,"profit":true},{"date":"2022-12-31","value":82.13,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Cost of Revenue | 36.52M | 41.45M | 74.40M | 101.58M | 112.90M | [{"date":"2019-12-31","value":32.35,"profit":true},{"date":"2020-12-31","value":36.72,"profit":true},{"date":"2021-12-31","value":65.9,"profit":true},{"date":"2022-12-31","value":89.97,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Gross Profit | 83.84M | 76.03M | 145.11M | 194.95M | 248.15M | [{"date":"2019-12-31","value":33.79,"profit":true},{"date":"2020-12-31","value":30.64,"profit":true},{"date":"2021-12-31","value":58.48,"profit":true},{"date":"2022-12-31","value":78.56,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Gross Margin | 69.66% | 64.71% | 66.11% | 65.74% | 68.73% | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":92.9,"profit":true},{"date":"2021-12-31","value":94.9,"profit":true},{"date":"2022-12-31","value":94.38,"profit":true},{"date":"2023-12-31","value":98.67,"profit":true}] |
Operating Expenses | 98.97M | 111.42M | 227.02M | 236.03M | 333.94M | [{"date":"2019-12-31","value":29.64,"profit":true},{"date":"2020-12-31","value":33.36,"profit":true},{"date":"2021-12-31","value":67.98,"profit":true},{"date":"2022-12-31","value":70.68,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Operating Income | (15.13M) | (35.39M) | (81.90M) | (41.08M) | (85.80M) | [{"date":"2019-12-31","value":-1512700000,"profit":false},{"date":"2020-12-31","value":-3538900000,"profit":false},{"date":"2021-12-31","value":-8190300000,"profit":false},{"date":"2022-12-31","value":-4108100000,"profit":false},{"date":"2023-12-31","value":-8579500000,"profit":false}] |
Total Non-Operating Income/Expense | 1.85M | 251.00K | 148.00K | 6.43M | 14.83M | [{"date":"2019-12-31","value":12.48,"profit":true},{"date":"2020-12-31","value":1.69,"profit":true},{"date":"2021-12-31","value":1,"profit":true},{"date":"2022-12-31","value":43.34,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Pre-Tax Income | (12.60M) | (34.91M) | (81.65M) | (36.43M) | (76.61M) | [{"date":"2019-12-31","value":-1259900000,"profit":false},{"date":"2020-12-31","value":-3490900000,"profit":false},{"date":"2021-12-31","value":-8164900000,"profit":false},{"date":"2022-12-31","value":-3642700000,"profit":false},{"date":"2023-12-31","value":-7661200000,"profit":false}] |
Income Taxes | 3.88M | 938.00K | (6.09M) | 133.00K | (2.21M) | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":24.16,"profit":true},{"date":"2021-12-31","value":-156.77,"profit":false},{"date":"2022-12-31","value":3.43,"profit":true},{"date":"2023-12-31","value":-56.88,"profit":false}] |
Income After Taxes | (16.48M) | (35.85M) | (75.56M) | (36.56M) | (74.40M) | [{"date":"2019-12-31","value":-1648100000,"profit":false},{"date":"2020-12-31","value":-3584700000,"profit":false},{"date":"2021-12-31","value":-7556300000,"profit":false},{"date":"2022-12-31","value":-3656000000,"profit":false},{"date":"2023-12-31","value":-7440400000,"profit":false}] |
Income From Continuous Operations | (12.60M) | (34.91M) | (75.56M) | (36.56M) | (49.95M) | [{"date":"2019-12-31","value":-1259900000,"profit":false},{"date":"2020-12-31","value":-3490900000,"profit":false},{"date":"2021-12-31","value":-7556300000,"profit":false},{"date":"2022-12-31","value":-3656000000,"profit":false},{"date":"2023-12-31","value":-4995500000,"profit":false}] |
Income From Discontinued Operations | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Net Income | (16.48M) | (35.85M) | (75.56M) | (36.56M) | (74.40M) | [{"date":"2019-12-31","value":-1648100000,"profit":false},{"date":"2020-12-31","value":-3584700000,"profit":false},{"date":"2021-12-31","value":-7556300000,"profit":false},{"date":"2022-12-31","value":-3656000000,"profit":false},{"date":"2023-12-31","value":-7440400000,"profit":false}] |
EPS (Diluted) | (0.27) | (0.68) | (0.59) | (0.50) | (1.03) | [{"date":"2019-12-31","value":-27,"profit":false},{"date":"2020-12-31","value":-68,"profit":false},{"date":"2021-12-31","value":-59,"profit":false},{"date":"2022-12-31","value":-50,"profit":false},{"date":"2023-12-31","value":-103,"profit":false}] |
These ratios help you determine the liquidity of the company. Higher is better.
VCYT | |
---|---|
Cash Ratio | 3.90 |
Current Ratio | 5.08 |
Quick Ratio | 4.79 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
VCYT | |
---|---|
ROA (LTM) | 1.07% |
ROE (LTM) | -0.83% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
VCYT | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 0.08 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.92 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
VCYT | |
---|---|
Trailing PE | NM |
Forward PE | 41.32 |
P/S (TTM) | 7.45 |
P/B | 2.57 |
Price/FCF | 114 |
EV/R | 6.52 |
EV/Ebitda | 160.88 |
PEG | NM |
Veracyte Inc (VCYT) share price today is $40.99
Yes, Indians can buy shares of Veracyte Inc (VCYT) on Vested. To buy Veracyte Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in VCYT stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of Veracyte Inc (VCYT) via the Vested app. You can start investing in Veracyte Inc (VCYT) with a minimum investment of $1.
You can invest in shares of Veracyte Inc (VCYT) via Vested in three simple steps:
The 52-week high price of Veracyte Inc (VCYT) is $46. The 52-week low price of Veracyte Inc (VCYT) is $18.61.
The price-to-earnings (P/E) ratio of Veracyte Inc (VCYT) is
The price-to-book (P/B) ratio of Veracyte Inc (VCYT) is 2.57
The dividend yield of Veracyte Inc (VCYT) is 0.00%
The market capitalization of Veracyte Inc (VCYT) is $3.17B
The stock symbol (or ticker) of Veracyte Inc is VCYT